SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 2,718.05 |
| Enterprise Value ($M) | 2,633.59 |
| Book Value ($M) | 532.58 |
| Book Value / Share | 7.16 |
| Price / Book | 5.10 |
| NCAV ($M) | 358.81 |
| NCAV / Share | 4.83 |
| Price / NCAV | 7.58 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.51 |
| Return on Assets (ROA) | -0.59 |
| Return on Equity (ROE) | -0.70 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.02 |
| Current Ratio | 6.16 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 435.11 |
| Assets | 608.88 |
| Liabilities | 76.30 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Boxer Capital Management, LLC | 4.60 | ||
| 13G/A | Deep Track Capital, LP | 5.53 | 24.88 | |
| 13G/A | EcoR1 Capital, LLC | 0.00 | -100.00 | |
| 13G/A | Vanguard Group Inc | 8.38 | 39.66 | |
| 13G/A | Fmr Llc | 15.00 | 15.48 | |
| 13G/A | BlackRock, Inc. | 7.50 | 61.88 | |
| 13G/A | State Street Corp | 3.64 | -30.25 | |
| 13D/A | Orbimed Advisors Llc | 4.90 | -14.63 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 962,367 | 2,865,025 | 33.59 | |
| 531,840 | 1,870,206 | 28.44 | |
| 410,792 | 2,013,183 | 20.41 | |
| 792,864 | 3,943,439 | 20.11 | |
| 297,202 | 1,280,856 | 23.20 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| STOK – Stoke Therapeutics, Inc. | STTK – Shattuck Labs, Inc. |
| SVRA – Savara Inc. | SYRE – Spyre Therapeutics, Inc. |
| SYRS – Syros Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io